EyePoint Pharmaceuticals
EYPT
#6133
Rank
โ‚น102.46 B
Marketcap
โ‚น1,222
Share price
-2.99%
Change (1 day)
35.36%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -โ‚น24.26 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น7.61 Million. In 2025 the company made an earning of -โ‚น22.37 Billion a decrease over its 2024 earnings that were of -โ‚น13.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น24.26 Billion8.46%
2025 -โ‚น22.37 Billion63.24%
2024 -โ‚น13.7 Billion104.29%
2023 -โ‚น6.71 Billion-29.88%
2022 -โ‚น9.57 Billion87.2%
2021 -โ‚น5.11 Billion38.58%
2020 -โ‚น3.69 Billion-24.56%
2019 -โ‚น4.89 Billion
2017 -โ‚น2.23 Billion22.59%
2016 -โ‚น1.82 Billion-8.02%
2015 -โ‚น1.98 Billion-296.09%
2014 โ‚น1.00 B-174.02%
2013 -โ‚น1.37 Billion37.42%
2012 -โ‚น1 Billion-56.29%
2011 -โ‚น2.27 Billion-1062.38%
2010 โ‚น0.23 B-250.43%
2009 -โ‚น0.16 Billion-89.5%
2008 -โ‚น1.5 Billion
2005 -โ‚น0.92 Billion56.99%
2004 -โ‚น0.59 Billion73.7%
2003 -โ‚น0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-99.20% Bahamas
NRC Health
NRC
โ‚น1.89 B-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA